DJ Catalyst Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ slid 1.60% to $22.12 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 0.94% to 19,630.97 and the Dow Jones Industrial Average rising 0.89% to 42,581.78.
This was the stock's fourth consecutive day of losses.
Catalyst Pharmaceuticals Inc. closed 16.78% short of its 52-week high of $26.58, which the company reached on June 9th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 1.02% to $151.32, Pfizer Inc. $(PFE)$ rose 0.25% to $24.03, and Abbott Laboratories $(ABT)$ rose 0.20% to $133.26.
Trading volume (1.3 M) eclipsed its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 23, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 23, 2025 17:23 ET (21:23 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.